Clinical Trial Update: A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 study of TQH3821 Tablets for treated rheumatoid arthritis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• TQH3821 Tablets (TQH3821)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED